Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01057615 · ClinicalTrials.gov registry record · Phase 1

Effect of Fish Oil and Vitamin C on Exercise-Induced Bronchoconstriction and Airway Inflammation in Asthma

A Phase 1 study, sponsored by Indiana University.

Completed
Registry status
Phase 1
Development phase
14
Enrollment target

NCT01057615 is a Phase 1 study that has completed, run by Indiana University. The registered enrollment target is 14 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01057615, a Phase 1 study, has completed, sponsored by Indiana University.

COMPLETED
Registry status
Phase 1
Development phase
14 participants
Enrollment target

Study Summary

Combining fish oil and vitamin C supplementation will provide a greater anti-inflammatory effect against developing exercise-induced bronchoconstriction (EIB) than either nutritional supplement alone.

Interventions

  • DIETARY_SUPPLEMENT Ascorbic Acid
  • DIETARY_SUPPLEMENT Fish Oil
  • DIETARY_SUPPLEMENT Fish Oil Placebo
  • DIETARY_SUPPLEMENT Ascorbic Acid Placebo

Trial Details

FieldValue
Enrollment Target 14 participants
Start Date 2010-03
Est. Completion 2010-12
Phase Phase 1

Sponsor

Indiana University

890 total trials

What the Registry Record Tells You About NCT01057615

The ClinicalTrials.gov registry entry for NCT01057615 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 4 interventions - of which Ascorbic Acid is the first listed.

NCT01057615 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01057615 about?

NCT01057615 is a clinical study titled "Effect of Fish Oil and Vitamin C on Exercise-Induced Bronchoconstriction and Airway Inflammation in Asthma". Combining fish oil and vitamin C supplementation will provide a greater anti-inflammatory effect against developing exercise-induced bronchoconstriction (EIB) than either nutritional supplement alone.

What is the current status of trial NCT01057615?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 14 participants. The study started on 2010-03. Estimated completion is 2010-12.

What interventions are being tested in trial NCT01057615?

The interventions under investigation include: Ascorbic Acid (DIETARY_SUPPLEMENT), Fish Oil (DIETARY_SUPPLEMENT), Fish Oil Placebo (DIETARY_SUPPLEMENT), Ascorbic Acid Placebo (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT01057615?

This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.